Form 4: EverQuote CEO Sells Shares Under Pre-Arranged 10b5-1 Plan
Insider Transaction Report
EverQuote, Inc. CEO and President Jayme Mendal sold 14,360 shares of Class A Common Stock for a weighted average price of $22.86 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Jayme Mendal, CEO and President of EverQuote, Inc., reported a sale of 14,360 shares of Class A Common Stock.
- The transaction occurred on August 20, 2025.
- The shares were sold at a weighted average price of $22.86 per share, with individual transaction prices ranging from $22.68 to $23.02.
- This sale was conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Mendal on December 17, 2024.
- Following this transaction, Mr. Mendal beneficially owns 512,780 shares of Class A Common Stock directly.
Sentiment
Score: 4
Explanation: The insider sale by the CEO is generally a negative signal, but the fact it was executed under a pre-arranged 10b5-1 plan mitigates some of the immediate negative interpretation, suggesting personal financial planning rather than a reaction to adverse company news.
Positives
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment rather than a reaction to recent company performance or news.
Negatives
- An insider sale by the CEO and President could be perceived negatively by investors, potentially signaling a lack of confidence or a desire to diversify personal holdings.
Risks
- Potential negative investor sentiment due to the insider sale, which could put downward pressure on the stock price.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide information directly related to broader industry trends or competitive landscape. Insider sales, even under 10b5-1 plans, are common across industries for personal financial planning.
Comparison to Industry Standards
- This filing is a standard Form 4 for an insider transaction. There are no specific company or project results to compare against global benchmarks or specific comparable companies. The transaction itself is a routine disclosure for executive stock sales.
Stakeholder Impact
- Shareholders: May experience negative sentiment or concern regarding the CEO's sale of shares, potentially leading to short-term stock price volatility.
Next Steps
- The filing does not mention any specific future actions, events, or milestones for the company or the reporting person beyond the execution of the pre-arranged trading plan.
Key Dates
| Date | Description |
|---|---|
| 2024-12-17 | Date Rule 10b5-1 trading plan was adopted by Jayme Mendal. |
| 2025-08-20 | Date of transaction where Class A Common Stock was sold. |
| 2025-08-22 | Date the Form 4 was signed by attorney-in-fact for Jayme Mendal. |
Recommendation
holdWhile an insider sale by the CEO is typically viewed negatively, the transaction was executed under a Rule 10b5-1 plan, which suggests a pre-planned divestment for personal financial management rather than a reaction to new adverse information. Without additional context on company performance or strategic shifts, this single transaction is not sufficient to warrant a 'buy' or 'sell' recommendation, thus a 'hold' is appropriate as investors should monitor future company developments.
Keywords
EverQuote, EVER, Jayme Mendal, insider trading, Form 4, stock sale, CEO, 10b5-1 plan, equity transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.